Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Serum Institute of India Pvt. Ltd., a biotechnology company that develops and manufactures vaccines for diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis B, measles, mumps, and rubella disease.
Serum Institute Of India Private Limited, is an unlisted private company incorporated on 22 May, 1984. It is classified as a private limited company and is located in , . It's authorized share capital is INR 55.00 cr and the total paid-up capital is INR 4.82 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Adar Cyrus Poonawalla
Shareholder
|
00044815 | 17 years |
Managing Director | Cyrus Soli Poonawalla
Shareholder
|
00044650 | 18 years |
Whole-time Director | Sunil Gairola | 08893242 | 4 years |
Whole-time Director | Umesh Sharadrao Shaligram | 00212458 | 4 years |
Whole-time Director | Satish Ramchandra Mundra | 00416654 | 15 years |
Whole-time Director | Natasha Adar Poonawalla | 01264082 | 9 years |
Whole-time Director | Prasad Suryakant Kulkarni | 08991838 | 4 years |
Director | Behroze Zavareh Poonawalla | 00044877 | 39 years |
Director | Zavareh Soli Poonawalla
Shareholder
|
00044760 | 41 years |
Whole-time Director | Kedar Shashikant Gokhale | 08788551 | 3 years |
Whole-Time Director | Parag Rajendra Deshmukh | 03377341 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
AMBIT CAPITAL PRIVATE LIMITED
No. of Loans: 1
Total Amount : 10.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SERUM INTERNATIONAL B.V. | Netherlands | - | - |
Bilthoven Biologicals B.V. | Netherlands | - | - |
SERUM INSTITUTE INC | United States | - | - |
Serum Life Science Europe Gmbh | Germany | - | - |
SEZ BIOTECH SERVICES PRIVATE LIMITED | 2006 | ₹ 1,300.4 Cr | |
POONAWALLA AVIATION PRIVATE LIMITED | Maharashtra | 2005 | ₹ 1,410.3 Cr |
Serum Life Sciences B.V | Netherlands | - | - |
Serum AMR Products B.V. | Netherlands | - | - |
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | 2020 | ₹ 636.6 Cr | |
Serum Life Sciences Ltd | United Kingdom | - | - |
COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED | Maharashtra | 2019 | ₹ 7.5 Cr |
SERUM INSTITUTE VACCINES PRIVATE LIMITED | Maharashtra | 2021 | ₹ 113.3 Cr |
SERUM LIFECARE FOUNDATION | Maharashtra | 2023 | ₹ 0.0 |
Serum Global FZCO | United Arab Emirates | - | - |
Serum Middle East Holdings FZCO | United Arab Emirates | - | - |
Diamond Worldwide Finance Ltd | United Kingdom | - | - |
Read more
The incorporation date of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 22 May, 1984
The authorized share capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 55.0 Cr.
The paid-up capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 4.8 Cr.
The registered address of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 212/2 OFF SOLI POONAWALLA ROAD, HADAPSAR, Pune, PUNE, Maharashtra, India, 411028 - 411028
The CIN number of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is U80903PN1984PTC032945.